ArticleJournal of clinical pharmacology2022
Leveraging a Previously Published Population Pharmacokinetic Model to Predict Rivaroxaban Exposure in Real-World Patients.
Daniel Weiner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.